XML 28 R7.htm IDEA: XBRL DOCUMENT v3.22.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Cash flows from operating activities    
Net loss $ (98,776) $ (67,475)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 355 334
Amortization of debt issuance costs 549  
Stock-based compensation expense 13,867 7,642
Noncash contract asset (105)  
Noncash lease expense 312 264
Noncash lease liability 309 362
Loss on fixed assets held for sale 243  
Unrealized gain on foreign currency transactions (930)  
Amortization of discount on investments   3
Changes in operating assets and liabilities:    
Refund Liability 22,163  
Contract asset (452)  
Prepaid expenses and other current assets, non-current assets, and accounts receivable (853) (3,919)
Accounts payable, accrued expenses and other long term-liabilities 7,841 1,877
Net cash used in operating activities (55,477) (60,912)
Cash flows from investing activities    
Maturities of short-term investments 1,474 8,193
Purchases of short-term investments   (8,931)
Deposit on property and equipment (1,793)  
Purchases of property and equipment (1,096)  
Net cash used in investing activities (1,415) (738)
Cash flows from financing activities    
Proceeds from exercise of stock options 1,199 1,020
Proceeds from notes payable, net of issuance costs 40,259  
Financing costs, paid (148)  
Proceeds from equity offerings, net of offering costs   108,196
Net cash provided by financing activities 41,310 109,216
Net (decrease) increase in cash and cash equivalents (15,582) 47,566
Cash and cash equivalents-beginning of period 138,509 90,943
Cash and cash equivalents-end of period 122,927 138,509
Supplemental disclosure of cash flow information    
Contractual exit fee included in notes payable 900  
Property and equipment in accrued expenses $ 43  
Financing in accounts payable and accrued expenses   $ 148